CEO Kevin Smith told investors at the KeyBanc Conference that the company has spent the past two years stabilizing operations ...
Peter Coates’s family welcome end to years pursuing answers after he died when outage stopped oxygen machine ...
The FDA approved a proximal hypoglossal nerve stimulation device (aura6000 system) for adults with moderate to severe obstructive sleep apnea (OSA), maker LivaNova announced on Thursday. FDA's ...
Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.
March 20, 2026. More for You ...
Immunomodulatory approaches such as GRI-0621 (RARβγ agonist targeting iNKT activity) may support alveolar basement membrane repair and provide complementary biology for oral combination regimens.